Anhui Meisaitai Biotechnology Co., Ltd. is a high-tech enterprise that focuses on providing core raw materials and overall solutions for the biopharmaceutical field.

The company targets core raw materials and new technology platforms in the international IVD industry, supported by high-end R&D and technical personnel. Focusing on mainstream IVD detection technology platforms and new detection projects such as chemiluminescence, immunoturbidimetry, gene molecules, POCT, etc., the company has established a research and development and production core raw material platform for single (multi) clonal antibodies, prokaryotic protein expression and purification, and nanomaterials, and has improved various IVD reagent kit production technology solutions, Provide one-stop full chain services from raw materials to reagent kit production processes for IVD production enterprises. Leading the development direction of IVD segmentation field, mastering core technologies, and solving bottleneck problems. Since its establishment, the company has completed the research and development of multiple antigen antibody and IVD kit processes, as well as small-scale production.

The company adheres to market demand orientation and innovation driven development as the main line, striving to build the company into a high-tech enterprise with leading technology, excellent products, first-class services, and industry reputation.